LivaNova PLC (LIVN) is a Healthcare stock trading at $78.47 (as of 2026-06-18), with a market capitalization of $4.05B and a trailing P/E of 40.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
LivaNova PLC designs, develops, manufactures, and sells therapeutic medical device solutions worldwide across Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Its offerings include cardiopulmonary products used in procedures requiring extracorporeal support, implantable vagus nerve stimulation therapies, and temporary life-support solutions, sold to clinicians and healthcare institutions.